(Q52872359)

English

The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis.

scientific article published in November 1993

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

1 reference

based on heuristic

inferred from title

author name string

Davenport A

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

publication date

1 November 1993

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

22

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

685-690

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of improved physical performance of chronic hemodialysis patients after erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Why are Alzheimer patients thin?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Skeletal muscle metabolism in uremic rats: a 31P-magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaemia and reduced exercise capacity in patients on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood lactate is reduced following successful treatment of anaemia in haemodialysis patients with recombinant human erythropoietin both at rest and after maximal exertion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of treatment with recombinant human erythropoietin on the histological appearance and glycogen content of skeletal muscle in patients with chronic renal failure treated by regular hospital haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Relaxation Rate of Constituent Muscle-Fibre Types in Human Quadriceps

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980431-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0272-6386(12)80431-8

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/8238014

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52872359&oldid=2228536821"